Skip to main content
. 2013 Feb 4;110(8):3005–3010. doi: 10.1073/pnas.1222900110

Table 1.

F→M HCT patient characteristics

Characteristic n
Total subjects 28
Primary disease
 Acute myelogenous leukemia 10
 Non-Hodgkin lymphoma 4
 Acute lymphoblastic leukemia 3
 Chronic lymphocytic leukemia 3
 Chronic myelogenous leukemia 3
 Other 5
Age, median (range), y 54 (21–65)
Conditioning regimen
 Myeloablative 13 (46%)
 Nonmyeloablative 15 (54%)
Donor
 Related 16 (57%)
 Unrelated 12 (43%)
cGVHD
 None 8 (29%)
 Mild 3 (11%)
 Moderate 12 (43%)
 Severe 5 (17%)
aGVHD
 Grade II–IV 9 (32%)
 None–grade I 19 (68%)
Survival, median (range), y 3.2 y (1–5.9)